Protection of Wistar-Furth rats against postischaemic acute renal injury: role for nitric oxide and thromboxane?

Virginie Voisin, Anne-Emilie Declèves, Virginie Hubert, Vanessa Colombaro, Laetitia Giordano, Isabelle Habsch, Nadine Bouby, Denis Nonclercq, Nathalie Caron

Résultats de recherche: Contribution à un journal/une revueArticleRevue par des pairs


The Wistar-Furth (WF) rat strain is usually used in models of full major histocompatibility complex-mismatched kidney transplantation. Because these rats have been demonstrated to be resistant to several models of chronic kidney disease, the aim of the present study was to investigate their potential resistance to renal ischaemia-reperfusion (I/R) injury compared with another strain, namely Wistar-Hanover (WH) rats. Anaesthetized male WH and WF rats were submitted to I/R by occlusion of the left renal artery and contralateral nephrectomy. Urine, blood and tissue samples were collected at different time points after I/R to evaluate renal function, inflammation and tubular injury, along with determination of nitric oxide synthase (NOS) expression and thromboxane A2 (TxA2 ) production. Post-ischaemic renal function was better preserved in WF than WH rats, as evidenced by reduced levels of creatininaemia, urinary neutrophil gelatinase-associated lipocalin excretion and proteinuria. In addition, WF rats had less intrarenal inflammation than WH rats after I/R injury. These observations were associated with maintenance of neuronal NOS expression, along with lower induction of inducible NOS expression in WF versus WH rats. Moreover, WF rats excreted a significantly lower amount of TxB2 . The results indicate that WF rats are more resistant to an I/R injury than WH rats in terms of renal function and inflammation. These observations are associated with differential regulation of intrarenal NOS expression, as well as a reduction in thromboxane production, which could contribute to a better outcome for the postischaemic kidney in WF rats.

langue originaleAnglais
Pages (de - à)911-20
Nombre de pages10
journalClinical and experimental pharmacology & physiology
Numéro de publication11
Les DOIs
Etat de la publicationPublié - 2014

Contient cette citation